- Home
- AUTL vs EH Comparison
AUTL vs EH Comparison
Compare AUTL & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | EH |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 532.3M | 436.9M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AUTL | EH |
|---|---|---|
| Price | $2.43 | $4.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.50 | ★ $22.47 |
| AVG Volume (30 Days) | ★ 3.3M | 612.0K |
| Earning Date | 05-14-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $80.32 | $33.23 |
| Revenue Next Year | $53.96 | $73.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $4.57 |
| 52 Week High | $2.58 | $20.20 |
Technical Indicators
Market Signals| Indicator | AUTL | EH |
|---|---|---|
| Relative Strength Index (RSI) | 64.81 | 39.89 |
| Support Level | $1.32 | $4.89 |
| Resistance Level | $2.43 | $6.15 |
| Average True Range (ATR) | 0.17 | 0.25 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 73.32 | 9.52 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company focused on autonomous aerial vehicle technology and solutions. The company provides unmanned aerial vehicle (UAV) systems and solutions for air mobility, including passenger transportation and logistics, as well as smart city management and aerial media solutions. Its EH216-S passenger-carrying pilotless eVTOL aircraft has obtained a production certificate and standard airworthiness certificate from the Civil Aviation Administration of China (CAAC).